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Introduction: Trauma stress and neuro-inﬂammation caused by surgery/anaesthesia releases cytokines.
This study analysed impact of Auditory Evoked Potential Index (AAI) depth-of-anaesthesia titration on
the early plasma IL-6 release after eye surgery under general anaesthesia.
Method: This is a subgroup analysis of a prospective randomized study on the effect of auditory evoked
potential guided anaesthesia for eye surgery. Plasma IL-6 levels taken before, 5 and 24 h after end of
surgery from 450 patients undergoing elective ophthalmic surgery under desﬂurane anaesthesia were
analysed. Minimal mental state examination (MMSE) was also tested at 24-h.
Results: IL- 6 increased signiﬁcantly at both 5 and further at 24 h after surgery (3.2, 4.5 and 5.1 base-line,
5 and 24-h respectively), the IL-6 increase showed different patterns between the 2 groups; IL-6 was
signiﬁcantly increased in the control group of patients between preoperative baseline and 24 h after
surgery (p ¼ 0.008) also between 5 h and 24 h, (p ¼ 0.006) after surgery while the AAI-group had only
minor non-signiﬁcant changes. The 18 patients that showed a 24-h MMSE score less than 25 had a
signiﬁcant higher 24-h IL-6 compared to the 390 patients with a MMSE score > 24 (p ¼ 0.002).
Conclusion: The IL-6 increase after surgery was less pronounced in patients where anaesthesia was
titrated by AAI compared to anaesthesia adjusted on clinical signs only. IL-6 were also found to be higher
in patients with a MMSE < 25 at 24-h. Further studies are warranted evaluating the role of depth of
anaesthesia monitoring on the risk for early cognitive impairment and neuro-inﬂammation.
Trial registration: Clinicaltrials.gov identiﬁer: NA/study were conducted between January 2005eApril
2008.
 2014 Surgical Associates Ltd. Published by Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Plasma IL-6 response is one marker of the stress response seen
in association with surgery, surgical stress and anaesthesia [1]. IL-6
is to part released from neuro-inﬂammation and passes into the
blood compartment [2,3]. Neuro-inﬂammation is believed to have a
role in the pathogenesis of postoperative delirium/confusion and
postoperative cognitive [3]. The contribution of surgical trauma,
anaesthesia per se and depth of anaesthesia on the inﬂammatory
response is not fully understood [1,4e6]. We showed in a previous
study that AEP monitoring (AAI-index) allowed dose reduction of
anaesthetic agents leading to better cardiovascular stability andn).
by Elsevier Ltd. Open access under Cdecreased requirements for intraoperative ﬂuids and vasopressors.
We also found signiﬁcantly lower incidence of minimal mental
state examination (MMSE) score <25 at 24-h after surgery/anaes-
thesia among the AAI guided group of patients that may have been
associated to the lower depth of anaesthesia and better cardio-
vascular stability [7]. The current study present the results of blood
samples taken for analysis of IL-6 from a sub-group of 450 patient
from this study.
The aim of this paper was to describe the results from analysis of
circulatory plasma concentrations of IL-6 and whether titration of
anaesthesia with a depth of anaesthesia monitor, the AAI-index,
had an impact on the plasma IL-6 response.
Our hypothesis was that optimising anaesthetic depth by titra-
tion anaesthesia delivery with AAI-index in patients undergoing
elective ophthalmic surgery in general anaesthesia based onC BY-NC-ND license.
Fig. 1. Shows randomisation procedure.
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(MMSE < 25) at 24 h could have an association to the IL-6 increase.2. Methods
The prospective randomised main study (Jildenstal et al. [7])
was approval by the Ethics Committee of Uppsala University hos-
pital, (Ethical Committee Nr. 2004: M-267, 27 September 2004,
President E Lempert) Uppsala, Sweden, prior to the start of the
study and the subsequent request for additional analysis of IL-6 was
approved in May 2011. Written, informed consent was obtained
from all patients prior to inclusion.3. Blood samples & evaluation of inﬂammatory response
after surgery
Blood samples for IL-6 analysis was taken from 450 patients
undergoing elective eye surgery in general anaesthesia; 224 in AAI-
group and 226 in control group. Forty-two patients were excluded
due to haemolysis of blood samples, but after allocation to the
treatment. Whole blood was drawn in EDTA-containing tubes at
baseline, at 5 h and 24 h postoperatively. The samples were
immediately transferred to the biomedical laboratory and centri-
fuged for 7 min at 2000 g. Plasma was removed and stored
at 70 C until analysis. The concentration of the inﬂammatory
marker IL-6 was measured in blood plasma [8e11], using an ELISAImmulite 1000 kit (Siemens Healtcare Diagnostics AB, 19487 Upp-
lands Väsby, Sweden).
Each serum sample was blindly analysed in duplicate and the
result was expressed as the mean of two measurements.4. Assessment of cognitive performance
The Minimal Mental State examination (MMSE) [12e14] was
performed at base-line and at 24 h. The test was done by a nurse
trained in the use of MMSE, blinded to the randomisation and
otherwise not active in the study. The maximum MMSE score is 30
points. We used a score of less than 25 at 24-h as the breaking score
for normal or non-normal based on Swedish reference data [13].
Patients were randomly assigned to one of two groups:
AAI-group: anaesthesia guided by AEP: A-line ARX index (AAI),
was calculated using the A-line monitor (Danmeter A/S, Odense,
Denmark) and AAI maintained between 15 and 25 [15].
Control group: anaesthesia guided according to clinical signs of
depth of anaesthesia. AAI was recorded in all patients in the control
group but was blinded to the attending anaesthetist. For random-
ization procedures see (Fig. 1).
All patients had standardised general anaesthesia based on
propofol and fentanyl induction. Anaesthesia was maintained with
nitrous oxide and desﬂurane in oxygen. All patients received
furthermore a sub-Tenon’s block with 2 ml bupivacaine 0.5%
(10 mg) before the start of surgery. No steroid, NSAIDs or Coxibs
were administered during the perioperative course.
Table 1
Patient’s characteristics data. Data is presented as mean  SD or median and range.
Characteristics data AAI-group (n ¼ 224) Control group (n ¼ 226)
Age, yr 60.0 (18.0e92.0) 60.5 (19.0e91.0)
Gender, M/F (n) 128/96 138/88
Weight, kg 77.3  14.2 79.7  14.7
ASA class 1, 2 (n) 198 203
ASA class 3 (n) 25 20
ASA class 4 (n) 1 3
Table 2
Mean  SD or median of all IL-6 (Q1, Q3) IL-6 changes in conjunction to ophthalmic
surgery in all patients (Mann Whitney U test, two sided p-value < 0.001).
IL-6 All patients (n ¼ 408) p-value
IL-6 pre (Mean, sd) (Md q1, q3) 3.8 (2.5)
3.2 (2.4; 4.2)
IL-6 5 h post (Mean, sd) (Md q1, q3) 7.6 (10.1) <0.01
4.5 (3.1; 7.1)
IL-6 24 h post (Mean, sd) (Md q1, q3) 12.8 (34.8) 0.001
5.1 (3.1; 10.5)
p-values comparison between time points.
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disease, cognitive impairment (diagnosis of dementia) or other
known inﬂammatory cerebral disease was excluded for partici-
pating in the study.5. Statistical methods
Descriptive statistics for the studymaterial are shown asmedian
(md), 1st and 3rd quartile (q1 and q3), mean, standard deviation
(sd) and percentage (%). Non-parametric methods were used to
analyse IL-6 since the measurements were not normally distrib-
uted. ManneWhitney U test was used for comparing IL-6 levels pre,
5 h and 24 h post-operation between the AAI and control group. ForFig. 2. Median of all IL-6 levels in AAI-group and control group. Baseline-preoperative and
lines, min, max value and outliers as indicated).within group comparisons, non-parametric ANOVA (Friedman test)
was used for testing difference in the IL-6 levels between the time
points: pre, 5 h and 24 h post-surgery. When overall ANOVA
identiﬁed a signiﬁcant difference between the three time points,
Wilcoxon paired signed-rank test was calculated.
A multivariate median regression model was used to determine
the risk factors association of (age, depth of anaesthesia, desﬂurane,
gender, BMI and cognitive function (MMSE) association with IL-6
24 h post-surgery [16e20]. The results from the model are pre-
sented as b (SE), p-value, 95% conﬁdence interval and R2 P-
values < 0.05 where considered signiﬁcant. Statistical analysis was
performed using SPSS (version 17), STATA (version 11) (version 17.0
SPSS Inc., Chicago, Illionois, USA). (StataCorp LP 4905 Lakeway
Drive College Station, Texas 77845-4512, USA and R (version 2.13.0).
Before the multivariate median regression analyse was perform
a correlation analysis and a univariate analysis was done as
required for that statistics model.6. Results
Blood samples for analysis of IL-6 was taken from 450 patients
but 42 patients were excluded due to haemolysis of blood samples.
The demographics of the two groups were similar (Table 1). The
were in all 44 ASA III and IV patients with cardiovascular medica-
tions 22 in each group AAI and control respectively.
The IL-6 for all patients increased over time, (Table 2, Fig. 2.).
There were no differences between the groups in IL-6 levels at
base-line or at 5 h after surgery (Table 3). The 24-h group median
values were signiﬁcantly different at 24-h (P  0.008) (Table 3). In
the control group IL-6 levels were signiﬁcantly increased between
preoperative baseline and 24 h after surgery (4.3 pg/ml (3.0; 8.5) vs.
5.0 pg/ml (3.2; 13.0), p ¼ 0.008), also between 5 h and 24 h after
surgery (0.02 (2.52; 1.93) 0.28 (5.8; 1.4), p ¼ 0.006). No
signiﬁcant increase was seen in AAI-group.
In all 18 patients had aMMSE score of less than 25 at 24-h test, 2
in the AAI-group and 16 in the control-group of patients. The IL-6postoperative 5 h and 24 h. (Boxplot, median value and interquartile range with broad
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assessed by a MMSE  24 was signiﬁcantly higher as compared to
the 390 patients that had a MMSE score > 24 P ¼ 0.002 (Table 4).
The multivariate median regression analysis showed age and
sex, male gender to be associated to an increased plasma IL-6
(P < 0.003 and 0.026 respectively) but no impact of BMI (Table 5).
7. Discussion
Our study is positive the increase in plasma IL-6 showed a
different pattern between the AAI-guided and control group of
patients, there was a signiﬁcant increase at 24 h in the control
group not seen in the patients where depth of anaesthesia was
adjusted in accordance to AAI-index 15e25. There was also a sig-
niﬁcant difference in group median IL-6 at 24-h between patients
with a MMSE  24 and those with MMSE > 24. This is as far as we
know the ﬁrst study showing titrating depth of anaesthesia by AAI
have an impact not only on amount of drug used, a more rapid
recovery and more stable intra-operative course but also a less
pronounce plasma IL-6 response.
Increase plasma level of inﬂammatory cytokines such as IL-6 is
commonly induced by surgical stress and even anaesthesia. IL-6 has
been shown to be a marker of neuro-inﬂammatory response and
may have an association to increased risk for postoperative
delirium and impair cognitive function especially in patients at riskTable 4
Mean SD or median (Q1, Q3), IL-6 changes and MMSE score at 24 h postop. in AAI-
group, control group and all patients (Mann Whitney U test, two sided p-
value**p ¼ 0.002 MMSE  24 vs. > 24).
MMSE AAI-group
(n ¼ 203)
Control group
(n ¼ 205)
All patients
(n ¼ 408)
MMSE  24 (n ¼ 18) 4.8 (4.4) 17.4 (14.2) 15.7 (14.3)
e 14.8 (7.0; 24.2) 12.5** (3.9; 22.5)
(n ¼ 2) (n ¼ 16) (n ¼ 18)
MMSE > 24 (n ¼ 390) 8.0 (11.0) 17.7 (49.3) 12.7 (35.5)
4.3 (3.0; 8.5) 4.7 (3.1; 11.8) 4.5 (3.1; 9.8)
(n ¼ 201) (n ¼ 189) (n ¼ 390)
All patients (n ¼ 408) 8.0 (11.0) 17.6 (47.5) 12.8 (34.8)
4.3 (3.0; 8.5) 5.0 (3.2; 13.0) 4.6 (3.1; 10.5)
**p ¼ 0.002 MMSE  24 vs. > 24.
Table 5
Multivariate median regression analysis for risk factors IL-6 24 h postoperatively control
Risk factors AAI-group (n ¼ 203) Control group (
R2 ¼ 0.01104095 R2 ¼ 0.0002736
b (SE) p-value 95% CI b (SE)
Age (yr) 0.02 (0.01) 0.04 (0.005 to 0.047) 0.04 (0.02)
Sex (men) 1.44 (0.46) 0.002 (0.53e2.341) 1.7 (0.72)
MMSE baseline 0.02 (0.31) 0.952 (0.621 to 0.584) 0.57 (0.36)
MMSE 24 h postop. 0.23 (0.28) 0.413 (0.327 to 0.793) 1.83 (0.26)
BMI 0.04 (0.06) 0.565 (0.09 to 0.165) 0.02 (0.15)
Desﬂurane 0.55 (0.4) 0.172 (1.353 to 0.244) 0.09 (0.48)
AAI-index 0.11 (0.13) 0.425 (0.364 to 0.154) 0.01 (0.29)
Table 3
Median of all IL-6 (Q1, Q3) IL-6 changes in AAI-group and control group (Mann
Whitney U test, two sided p-value < 0.0001).
IL-6 AAI-group
(n ¼ 203)
Control group
(n ¼ 205)
p-value
Preop. Md (q1, q3) 3.1 (2.5; 4.2) 3.2 (2.4; 4.2) 0.887
5 h postop. Md (q1, q3) 4.5 (3.1; 6.5) 4.5 (3.1; 8.3) 0.372
24 h postop. Md (q1, q3) 4.3 (3.0; 8.5) 5.0 (3.2; 13.0) 0.008
p-values comparison between AEP and control.[1,3,21,22]. Severe neuro-inﬂammatory response may cause not
only prolonged cognitive recovery as seen in our study but may also
be associated to protracted postoperative cognitive dysfunction
(POCD) [23,24]. POCD decreases the patients’ life quality and has
been associated with increase in surgical morbidity and mortality
[1,19,25]. There is good evidence that increased expression of pro-
inﬂammatory cytokines such as IL-6 inﬂuence performance deﬁ-
cits in hippocampus dependent cognitive memory [1,26e28]. I.V.
administration of IL-6 in rats and humans has been shown to
contribute to activation of inﬂammatory response in brain and in-
crease POCD [29,30]. Meyers et al. found that increased IL-6 levels
were associated with cognitive impairment, especially poorer ex-
ecutive function, in patients with acute myelogenous leukaemia
and myelodysplastic syndrome before the initiation of their treat-
ment [31].
We found IL-6 to increase both at 5 and 24 h after surgery.
Hogvold et al. found IL6 peaked at 4 h after hip replacement and no
difference between regional or general anaesthesia but they did not
examine cognitive function [32].
The increase in IL-6 was of moderate intensity but still signiﬁ-
cantly different between the groups studied. We choose to study
patients undergoing elective eye surgery as the stress and subse-
quent neuro-inﬂammation associated with eye surgery under
general anaesthesia should reasonably be minor [1,19,20,30,33,34].
Still Tu et al. have shown a rise in serum and aqueous cytokines
even after cataract surgery [34]. All patients followed a stand-
ardised anaesthesia protocol. Anaesthesia was maintained with
nitrous oxide and desﬂurane in oxygen and all patients received
prior to start of surgery a sub-Tenon’s block with 2 ml bupivacaine
0.5%. Thus we believe that the increase in IL-6 could be mainly
attributable to anaesthetic. Many factors, disease process and sur-
gery per see, may cause increase in IL-6 and thus our results must
be interpretedwith caution [35,36]. It should be acknowledged that
there are suggests that general anaesthesia per se does not lead to
any signiﬁcant increase in IL6 [37].
There where only few patients with a 24-h MMSE score below
set break-point. Still the group of patients with a 24-h MMSE score
less than 25 had a signiﬁcantly higher IL-6 at 24 h as compared to
the patients that did not show any signs of cognitive decline. It is
from the present study not possible to state whether there is causal
relation between neuro-inﬂammation, increased in IL-6 and post-
operative cognitive dysfunction [2]. Our results regarding the as-
sociation between plasma IL-6 and worse cognitive performance,
assessed as a MMSE score <25, are however consistent with the
ﬁndings from other studies [1,8,9,11,38,39]. We used the minimal
mental state examination to assess and compare cognitive capacity.
The MMSE is frequently used as a screen tool for assessment of
cognitive deﬁcit [13]. It should however not be seen as a surrogate
for POCD test battery as described by Krenk and Rasmussen [40].
Further studies are necessary to conﬁrm whether POCD diagnosisled for IL-6 baseline.
n ¼ 205) All (n ¼ 408)
R2 ¼ 0.0013536
p-value 95% CI b (SE) p-value 95% CI
0.03 (0.08 to 0.087) 0.03 (0.01) 0.003 (0.011e0.055)
0.019 (3.117 to 0.283) 2.99 (1.34) 0.026 (0.356e5.624)
0.112 (0.134 to 1.274) 0.22 (0.2) 0.261 (0.612 to 0.166)
<0.001 (2.346 to 1.324) 0.8 (0.12) <0.001 (1.045 to 0.56)
0.876 (0.269 to 0.316) 0.04 (0.06) 0.479 (0.168 to 0.079)
0.855 (0.863 to 1.04) 0.64 (0.24) 0.008 (1.114 to 0.172)
0.002 (0.674 to 0.416) 0.08 (0.12) 0.511 (0.308 to 0.154)
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various neuropsychological tests used.
There are limitation with our study. We studied IL-6 only and
compared the plasma concentration at base-line, 5 h and 24 h after
surgery. A more protracted time period for follow-up of IL-6 as well
as cognitive performance would be of huge importance. It is from
our study furthermore not possible to assess the origin for the IL-6
increase, indeed many factors may contribute to the release of IL-6
[35]. The groups were seemingly well matched and other factors
that may have inﬂuenced IL-6 release e.g. cardiovascular medica-
tionwas as far as we can see equal [41,42]. We did not use anymore
extensive test battery for cognitive function. The MMSE assessed at
24-h with a cut-off of above or under 25 is a may not be seen as an
optimal marker for cognitive impairment. The MMSE is intended
merely a simple and easy to perform general screening tool. There
are alternative tools such as the MOCA [Montreal Cognitive
Assessment] that may have been more sensitive than the widely
used MMSE test [43]. Our cognitive test results may merely be seen
more as a marker of slow recovery than of postoperative cognitive
dysfunction.
In conclusion, plasma IL-6 levels increased during the ﬁrst 24 h
post surgery/anaesthesia, however the increase in IL-6 showed a
different pattern, the AAI-group of patients had a signiﬁcant lower
IL-6 at 24 h as compared to the control group of patients. The in
with a MMSE score < 25 was found to have higher IL-6 at 24 h as
compared to patients with MMSE > 24. Further studies are war-
ranted evaluatingwhether administration of anaesthetic titrated by
depth of anaesthesia monitor, AAI, could inﬂuence the cytokine
response associated to surgery/anaesthesia and possibly have some
neuro-protecting effects.Ethical approval
Approval by the Ethics Committee of Uppsala University hos-
pital, (Ethical Committee Nr. 2004: M-267, 27 September 2004,
President E Lempert) Uppsala, Sweden.Funding
The scientiﬁc committee of Örebro county council sponsored
the study.Author contributions
Pether Jildenstål, Narinder Rawal Lars Berggren and Jan Hallén
contributed to the conception of the study. Pether Jildenstål, Nar-
inder Rawal and Jan Hallén contributed to the study design. Pether
Jildenstål and Jan Hallén took an active part in setting up the in-
clusion and exclusion criteria. Pether Jildenstål and Narinder Rawal
supervised the acquisition, analysis, and interpretation of data.
Pether Jildenstål, Narinder Rawal and Lars Berggren participated in
the analysis of data and drafted the ﬁrst version of the manuscript.
Pether Jildenstål, Narinder Rawal, Lars Berggren, Jan Hallén and Jan
Jakobsson were involved in the interpretation of the data. Pether
Jildenstål, Narinder Rawal, Lars Berggren, Jan Hallén and Jan
Jakobsson all played a signiﬁcant role in revising themanuscript for
intellectual content.Conﬂicts of interest related to this study
None.Acknowledgements
The scientiﬁc committee of Örebro county council sponsored
the study.
References
[1] Y.C. Li, C.H. Xi, Y.F. An, W.H. Dong, M. Zhou, Perioperative inﬂammatory
response and protein S-100beta concentrations - relationship with post-
operative cognitive dysfunction in elderly patients, Acta Anaesthesiologica
Scandinavica 56 (5) (2012) 595e600.
[2] R.N. Dilger, R.W. Johnson, Aging, microglial cell priming, and the discordant
central inﬂammatory response to signals from the peripheral immune system,
Journal of Leukocyte Biology 84 (4) (2008) 932e939.
[3] E. Beurel, R.S. Jope, Lipopolysaccharide-induced interleukin-6 production is
controlled by glycogen synthase kinase-3 and STAT3 in the brain, Journal of
Neuroinﬂammation 6 (2009) 9.
[4] W.A. van Gool, D. van de Beek, P. Eikelenboom, Systemic infection and
delirium: when cytokines and acetylcholine collide, Lancet 375 (9716) (2010)
773e775.
[5] F.M. Radtke, M. Franck, J. Lendner, S. Kruger, K.D. Wernecke, C.D. Spies,
Monitoring depth of anaesthesia in a randomized trial decreases the rate of
postoperative delirium but not postoperative cognitive dysfunction, British
Journal of Anaesthesia 110 (Suppl. 1) (2013) i98ei105.
[6] B. Silbert, L. Evered, D.A. Scott, Cognitive decline in the elderly: is anaesthesia
implicated? Best Practice & Research Clinical Anaesthesiology 25 (3) (2011)
379e393.
[7] P.K. Jildenstal, J.L. Hallen, N. Rawal, A. Gupta, L. Berggren, Effect of auditory
evoked potential-guided anaesthesia on consumption of anaesthetics and
early postoperative cognitive dysfunction: a randomised controlled trial, Eu-
ropean Journal of Anaesthesiology 28 (3) (2011) 213e219.
[8] D. Borsook, E. George, B. Kussman, L. Becerra, Anesthesia and perioperative
stress: consequences on neural networks and postoperative behaviors, Prog-
ress in Neurobiology 92 (4) (2010) 601e612.
[9] R.J. Hall, S.D. Shenkin, A.M. Maclullich, A systematic literature review of ce-
rebrospinal ﬂuid biomarkers in delirium, Dementia and Geriatric Cognitive
Disorders 32 (2) (2011) 79e93.
[10] P. Sheeran, G.M. Hall, Cytokines in anaesthesia, British Journal of Anaesthesia
78 (2) (1997) 201e219.
[11] G. Xie, W. Zhang, Y. Chang, Q. Chu, Relationship between perioperative in-
ﬂammatory response and postoperative cognitive dysfunction in the elderly,
Medical Hypotheses 73 (3) (2009) 402e403.
[12] M.F. Folstein, S.E. Folstein, P.R. McHugh, “Mini-mental state”. A practical
method for grading the cognitive state of patients for the clinician, Journal of
Psychiatric Research 12 (3) (1975) 189e198.
[13] M. Grut, L. Fratiglioni, M. Viitanen, B. Winblad, Accuracy of the mini-mental
status examination as a screening test for dementia in a Swedish elderly
population, Acta Neurologica Scandinavica 87 (4) (1993) 312e317.
[14] T.N. Tombaugh, N.J. McIntyre, The mini-mental state examination: a
comprehensive review, Journal of the American Geriatrics Society 40 (9)
(1992) 922e935.
[15] G. Plourde, Auditory evoked potentials, Best Practice & Research Clinical
Anaesthesiology 20 (1) (2006) 129e139.
[16] D.J. Culley, R.Y. Yukhananov, Z. Xie, R.R. Gali, R.E. Tanzi, G. Crosby, Altered
hippocampal gene expression 2 days after general anesthesia in rats, Euro-
pean Journal of Pharmacology 549 (1e3) (2006) 71e78.
[17] J.P. Desborough, The stress response to trauma and surgery, British Journal of
Anaesthesia 85 (1) (2000) 109e117.
[18] J.A. Hudetz, S.D. Gandhi, Z. Iqbal, K.M. Patterson, P.S. Pagel, Elevated post-
operative inﬂammatory biomarkers are associated with short- and medium-
term cognitive dysfunction after coronary artery surgery, Journal of Anes-
thesia 25 (1) (2011) 1e9.
[19] T.G. Monk, B.C. Weldon, C.W. Garvan, et al., Predictors of cognitive dysfunc-
tion after major noncardiac surgery, Anesthesiology 108 (1) (2008) 18e30.
[20] S. Newman, J. Stygall, S. Hirani, S. Shaeﬁ, M. Maze, Postoperative cognitive
dysfunction after noncardiac surgery: a systematic review, Anesthesiology
106 (3) (2007) 572e590.
[21] X.Z. Cao, H. Ma, J.K. Wang, et al., Postoperative cognitive deﬁcits and neuro-
inﬂammation in the hippocampus triggered by surgical trauma are exacer-
bated in aged rats, Progress in Neuro-Psychopharmacology & Biological
Psychiatry 34 (8) (2010) 1426e1432.
[22] T. Sun, X. Wang, Z. Liu, X. Chen, J. Zhang, Plasma concentrations of pro- and
anti-inﬂammatory cytokines and outcome prediction in elderly hip fracture
patients, Injury 42 (7) (2011) 707e713.
[23] H.A. Rosczyk, N.L. Sparkman, R.W. Johnson, Neuroinﬂammation and cognitive
function in aged mice following minor surgery, Experimental Gerontology 43
(9) (2008) 840e846.
[24] Y. Wan, J. Xu, F. Meng, et al., Cognitive decline following major surgery is
associated with gliosis, beta-amyloid accumulation, and tau phosphorylation
in old mice, Critical Care Medicine 38 (11) (2010) 2190e2198.
[25] J. Steinmetz, K.B. Christensen, T. Lund, N. Lohse, L.S. Rasmussen, Long-term
consequences of postoperative cognitive dysfunction, Anesthesiology 110 (3)
(2009) 548e555.
P.K. Jildenstål et al. / International Journal of Surgery 12 (2014) 290e295 295
ORIGINAL RESEARCH[26] V.H. Perry, C. Cunningham, C. Holmes, Systemic infections and inﬂammation
affect chronic neurodegeneration, Nature Reviews Immunology 7 (2) (2007)
161e167.
[27] M. Pickering, D. Cumiskey, J.J. O’Connor, Actions of TNF-alpha on gluta-
matergic synaptic transmission in the central nervous system, Experimental
Physiology 90 (5) (2005) 663e670.
[28] Z. Zuo, Postoperative cognitive effects in newborns: the role of inﬂammatory
processes, Anesthesiology 118 (3) (2013) 481e483.
[29] E. Spath-Schwalbe, K. Hansen, F. Schmidt, et al., Acute effects of recombinant
human interleukin-6 on endocrine and central nervous sleep functions in
healthy men, The Journal of Clinical Endocrinology and Metabolism 83 (5)
(1998) 1573e1579.
[30] Y. Wan, J. Xu, D. Ma, Y. Zeng, M. Cibelli, M. Maze, Postoperative impairment of
cognitive function in rats: a possible role for cytokine-mediated inﬂammation
in the hippocampus, Anesthesiology 106 (3) (2007) 436e443.
[31] C.A. Meyers, M. Albitar, E. Estey, Cognitive impairment, fatigue, and cytokine
levels in patients with acute myelogenous leukemia or myelodysplastic syn-
drome, Cancer 104 (4) (2005) 788e793.
[32] H.E. Høgevold, T. Lyberg, H. Kähler, E. Haug, O. Reikerås, Changes in plasma IL-
1beta, TNF-alpha and IL-6 after total hip replacement surgery in general or
regionalanaesthesia, Cytokine 12 (2000) 1156e1159.
[33] M. Tylman, R. Sarbinowski, J.P. Bengtson, A. Kvarnstrom, A. Bengtsson, In-
ﬂammatory response in patients undergoing colorectal cancer surgery: the
effect of two different anesthetic techniques, Minerva Anestesiologica 77 (3)
(2011) 275e282.
[34] K.L. Tu, S.B. Kaye, G. Sidaras, W. Taylor, A. Shenkin, Effect of intraocular sur-
gery and ketamine on aqueous and serum cytokines, Molecular Vision 13
(2007) 1130e1137.[35] S. Larson, A.J. Dunn, Behavioral effects of cytokines, Brain, Behavior, and Im-
munity 15 (2001) 371e387.
[36] N. Caza, R. Taha, Y. Qi, G. Blaise, The effects of surgery and anesthesia on
memory and cognition, Progress in Brain Research 169 (2008) 409e422.
[37] J.M. Brand, H. Kirchner, C. Poppe, P. Schmucker, The effects of general anes-
thesia on human peripheral immune cell distribution and cytokine produc-
tion, Clinical Immunology and Immunopathology 83 (1997) 190e194.
[38] M. Cibelli, A.R. Fidalgo, N. Terrando, et al., Role of interleukin-1beta in post-
operative cognitive dysfunction, Annals of Neurology 68 (3) (2010) 360e368.
[39] L.S. Rasmussen, K. Larsen, P. Houx, L.T. Skovgaard, C.D. Hanning, J.T. Moller,
The assessment of postoperative cognitive function, Acta Anaesthesiologica
Scandinavica 45 (3) (2001) 275e289.
[40] L. Krenk, L.S. Rasmussen, Postoperative delirium and postoperative cognitive
dysfunction in the elderly - what are the differences? Minerva Anestesiologica
77 (7) (2011) 742e749.
[41] D.J. Brull, J. Sanders, A. Rumley, G.D. Lowe, S.E. Humphries, H.E. Montgomery,
Impact of angiotensin converting enzyme inhibition on post-coronary artery
bypass interleukin 6 release, Heart 87 (2002) 252e255.
[42] N. Mabuchi, T. Tsutamoto, M. Kinoshita, Therapeutic use of dopamine and
beta-blockers modulates plasma interleukin-6 levels in patients with
congestive heart failure, Journal of Cardiovascular Pharmacology 36 (Suppl. 2)
(2000) S87eS91.
[43] S. Hoops, S. Nazem, A.D. Siderowf, et al., Validity of the MoCA and MMSE in
the detection of MCI and dementia in Parkinson disease, Neurology 73 (21)
(2009) 1738e1745.
